NCT04157972View on ClinicalTrials.gov

Effects of SIMEOX on Static Hyperinflation in Patients With COPD

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

March 16, 2021

Study Completion Date

March 16, 2021

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE

SIMEOX

SIMEOX is a device generating a succession of gentle depression at the mouth.

DEVICE

PEP

A PEP device (Pari-PEP) will be used to provoke a positive expiratory pressure while exhaling, thereby stabilizing the airways during expiration.

Trial Locations (1)

1200

Cliniques universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT04157972 - Effects of SIMEOX on Static Hyperinflation in Patients With COPD | Biotech Hunter | Biotech Hunter